Probing the properties of PTEN specific botulinum toxin type E mutants.
Abstract
Botulinum neurotoxins (BoNT) are established biopharmaceuticals for neuromuscular and secretory conditions based on their ability to block neurotransmitter release from neurons by proteolyzing specific soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. Recently, a mutant catalytic domain of serotype E (LC/E) exhibiting 16 mutations was reported to cleave the phosphatase and tensin homolog (PTEN). This molecule represents an attractive new target in neurons as several reports support PTEN knockdown as a strategy to stimulate axonal regeneration after injury. Though this LC/E mutant was shown to cleave PTEN in primary neurons through lentivirus-based expression, its expression and functionality as mutated full-length BoNT/E have not been studied. Hence, we assembled the 16 mutations stepwise in a bacterial expression plasmid for LC/E and purified several multiple mutants of LC/E. Biochemical characterization showed that the 16-fold mutant did not exhibit a detectable activity toward SNAP-25 up to 10 µM final concentration while it displayed an EC of approximately 200 nM for PTEN, exceeding 1000-fold that for LC/E-wt on the native substrate SNAP-25. Unexpectedly, expression of the full length 16-fold mutated BoNT/E did not provide soluble protein, possibly due to an interference of the interaction between LC and the translocation domain. Reversion of individual mutations revealed the E159L and S162Q substitutions, critical for redirecting LC/E activity toward PTEN, as main culprits for the solubility issue. To overcome this problem, we applied a methodology proved successful years ago, harnessing a proteolytically inactive variant of BoNT type D (BoNT/Di) as neurospecific delivery system for cargo proteins. The fusion protein LCE-16x-BoNT/Di could be produced in sufficient yields. Activity tests using rat cerebellar granule neurons showed BoNT/E-like activity for LC/E-wt-BoNT/Di, but no PTEN-directed activity for LC/E-16x-BoNT/Di.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | neuromuscular
|
scispacy | 1 | ||
| 해부 | neurotransmitter
|
scispacy | 1 | ||
| 해부 | neurons
|
scispacy | 1 | ||
| 해부 | BoNT/E
|
scispacy | 1 | ||
| 해부 | LCE-16x-BoNT/Di
|
scispacy | 1 | ||
| 약물 | BoNT/E
|
scispacy | 1 | ||
| 약물 | BoNT
→ Botulinum neurotoxins
|
scispacy | 1 | ||
| 기타 | PTEN
→ phosphatase and tensin homolog
|
scispacy | 1 | ||
| 기타 | botulinum toxin type E
|
scispacy | 1 | ||
| 기타 | LC/E
|
scispacy | 1 | ||
| 기타 | lentivirus-based
|
scispacy | 1 | ||
| 기타 | BoNT/E
|
scispacy | 1 | ||
| 기타 | SNAP-25
|
scispacy | 1 | ||
| 기타 | BoNT type D
|
scispacy | 1 | ||
| 기타 | neurospecific
|
scispacy | 1 | ||
| 기타 | rat cerebellar granule neurons
|
scispacy | 1 |
MeSH Terms
Animals; PTEN Phosphohydrolase; Rats; Botulinum Toxins; Synaptosomal-Associated Protein 25; Mutation; Neurons; Humans
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.